Johnson & Johnson (JNJ)

PJP delivered a higher return over the past year -- but IYH charges lower fees and pays a higher dividend yield.

J&J has more than 28 sources of blockbuster revenue.

They can help stabilize your portfolio in these otherwise volatile times.

A tech selloff hit the S&P 500 and NASDAQ this week while energy and financial stocks gained; MarketBeat analysts recap Micron, Netflix, Broadcom, Apple and more ahead of Alphabet's earnings.

The reasons why RBC Capital Markets maintains its stock rating.

One generates steady cash flow with a lower valuation; the other is growing at 45% but carries higher leverage.

IHE concentrates on giants such as Johnson & Johnson and Eli Lilly, while XPH spreads risk across 65 holdings with different volatility profiles.

Johnson & Johnson (NYSE:JNJ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to

Investors didn't seem to think so after the company published it.

Johnson & Johnson's post-earnings pullback follows a revenue and EPS beat, raised guidance, and analyst price target increases, with talc litigation remaining the key risk to watch.

Johnson & Johnson (NYSE:JNJ) raised its full-year 2026 outlook after reporting second-quarter sales growth that management said was supported by strength in Innovative Medicine, new product launches and a broad portfolio that helped offset continued pressure from STELARA biosimilar competition.

Johnson & Johnson beats Q2 2026 Wall Street estimates and raises full-year guidance as sales top $25B, driven by oncology and MedTech.

Morgan Stanley, Pentair, Johnson & Johnson expected to release earnings, ASML posts strong results, Progressive to report

Johnson & Johnson stock trades near all-time highs. A strong Q2 report and the chart show more upside ahead.

Earnings report for JNJ expected on July 15, with analysts predicting $2.85/share & $25.06B revenue. Stock price target raised to $287/share.

The dividend looks secure. The share price is the harder call.

Why are chip stocks collapsing while the Dow barely budges? Korean markets just had their worst day since the 2008 financial crisis, and the fallout is hitting semiconductors hard.

As investors flee this year's high flyers, a few dependable payers are catching the money.

Griffin is at the helm of the world's most profitable hedge fund.